Know Cancer

or
forgot password

Benign Acute Pericarditis: Brief Versus Longer Treatment. Randomized, Multicentric, Double Blind, Non Inferiority Trial


Phase 4
18 Years
N/A
Not Enrolling
Both
Pericarditis

Thank you

Trial Information

Benign Acute Pericarditis: Brief Versus Longer Treatment. Randomized, Multicentric, Double Blind, Non Inferiority Trial


Inclusion Criteria:



- age over 18

- first episode of acute pericarditis

- chest pain lasting less than 24 hours

Exclusion Criteria:

- contraindication to aspirin

- previous history of atypical chest pain

- previous history of connective tissue disease, tuberculosis, recent MI, auto immune
disease, neoplastic disease, thoracic trauma, previous thoracic surgery, antiplatelet
routine treatment, anticoagulation

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

recovery

Outcome Time Frame:

30 days

Safety Issue:

No

Principal Investigator

jean-christophe cornily, md

Investigator Role:

Principal Investigator

Investigator Affiliation:

FESC, Fellow of the french society of cardiology

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

PERICARDITE

NCT ID:

NCT00946907

Start Date:

July 2009

Completion Date:

July 2011

Related Keywords:

  • Pericarditis
  • acute pericarditis
  • treatment
  • recurrence
  • Pericarditis

Name

Location